Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Atara BiotherapeuticsAVITA MED LTD/SBAVARIAN NORDIC/SMesoblastKrystal Biotech
SymbolNASDAQ:ATRANASDAQ:RCELOTCMKTS:BVNRYNASDAQ:MESONASDAQ:KRYS
Price Information
Current Price$13.19$9.90$12.25$9.24$59.28
52 Week RangeBuyBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$29.88$12.00N/A$13.83$72.50
% Upside from Price Target126.50% upside21.21% upsideN/A49.71% upside22.30% upside
Trade Information
Market Cap$732.11 million$846.87 million$1.19 billion$931.48 million$1.05 billion
Beta2.081.310.521.741.18
Average Volume522,482467,71222370,750105,238
Sales & Book Value
Annual RevenueN/A$5.51 million$79.30 million$16.72 millionN/A
Price / SalesN/A148.4514.9755.11N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$7.42 per share$1.03 per share$3.56 per share$4.82 per share$7.85 per share
Price / BookN/A9.613.441.92N/A
Profitability
Net Income$-230,700,000.00$-24,750,000.00$-57,330,000.00$-89,800,000.00$-10,890,000.00
EPS($5.27)($0.39)($0.59)($0.91)($0.97)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A25.00N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-72.61%-342.39%N/A
Return on Equity (ROE)-99.70%N/A-19.55%-15.30%-11.08%
Return on Assets (ROA)-86.31%N/A-14.39%-11.35%-10.70%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%0.03%0.24%0.14%0.01%
Current Ratio9.56%15.36%7.43%0.86%54.87%
Quick Ratio9.56%5.33%7.08%0.86%54.87%
Ownership Information
Institutional Ownership PercentageN/A0.12%N/A4.18%64.60%
Insider Ownership Percentage7.00%N/AN/A18.80%34.30%
Miscellaneous
Employees321N/A4198137
Shares Outstanding54.15 million82.62 million96.93 million99.73 million17.31 million
Next Earnings Date2/27/2020 (Confirmed)N/A3/19/2020 (Estimated)2/26/2020 (Estimated)3/10/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel